BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17824363)

  • 1. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
    Volante R; Giubilato P; Ronco G
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):61-8. PubMed ID: 17824363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of colposcopy and treatment--data from the national survey of Italian organised cervical screening programmes: 2006 activity.
    Volante R; Giubilato P; Ronco G
    Epidemiol Prev; 2009; 33(3 Suppl 2):75-82. PubMed ID: 19776488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity].
    Volante R; Giubilato P; Ronco G
    Epidemiol Prev; 2012; 36(6 Suppl 1):78-86. PubMed ID: 23293272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in Italy: quality of colposcopy and treatment. 2009 activity.
    Ronco G; Volante R; Giubilato P
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):78-86. PubMed ID: 22166351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes. 2008 activity.
    Volante R; Giubilato P; Ronco G
    Epidemiol Prev; 2010; 34(5-6 Suppl 4):73-80. PubMed ID: 21220838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
    Volante R; Giubilato P; Ronco G
    Epidemiol Prev; 2008; 32(2 Suppl 1):69-76. PubMed ID: 18773525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National survey of the quality of 2nd level in screening for cervical cancer.
    Volante R; Ronco G
    Epidemiol Prev; 2006; 30(1 Suppl 3):51-7. PubMed ID: 16937846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity.
    Ronco G; Giubilato P; Carozzi F; Maia G; Giorgi Rossi P; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):61-76. PubMed ID: 26405778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2009; 33(3 Suppl 2):41-56. PubMed ID: 19776486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical excisional treatment of young women: a population-based study.
    Kinney W; Hunt WC; Dinkelspiel H; Robertson M; Cuzick J; Wheeler CM;
    Gynecol Oncol; 2014 Mar; 132(3):628-35. PubMed ID: 24395062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the recurrence and residual lesions incidence after loop electroexcisional procedure and cold knife conisation].
    Kabzińska-Turek M; Basta A; Stangel-Wójcikiewicz K; Knafel A; Zajac K; Przybylska-Jurecka P; Jach R; Milewicz T
    Przegl Lek; 2012; 69(9):658-62. PubMed ID: 23401984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity].
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):39-54. PubMed ID: 23293270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyto-colpo-histologic correlation: about an analytical study of 120 colposcopies.
    Slimani O; Ben Temim R; Makhlouf T; Mathlouthi N; Attia L
    Tunis Med; 2016 Oct; 94(8-9):616-620. PubMed ID: 28685798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
    Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
    J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.
    Pan QJ; Hu SY; Zhang X; Ci PW; Zhang WH; Guo HQ; Cao J; Zhao FH; Lytwyn A; Qiao YL
    Cancer Cytopathol; 2013 Sep; 121(9):473-82. PubMed ID: 23907807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.